NCLEX | VSGIX | NCLEX / VSGIX | |
Total Expense Ratio | 0.85 | 0.06 | 1,417% |
Annual Report Gross Expense Ratio | 0.85 | 0.06 | 1,417% |
Fund Existence | 38 years | 25 years | - |
Gain YTD | -5.770 | 6.636 | -87% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 5000000 | 2% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 442M | 38.6B | 1% |
Annual Yield % from dividends | 0.00 | 0.52 | - |
Returns for 1 year | -4.67 | 15.15 | -31% |
Returns for 3 years | 6.44 | 41.97 | 15% |
Returns for 5 years | -0.73 | 40.32 | -2% |
Returns for 10 years | 14.08 | 142.21 | 10% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
VGK | 79.95 | 0.59 | +0.74% |
Vanguard FTSE Europe ETF | |||
CHI | 10.61 | 0.03 | +0.33% |
Calamos Convertible Opportunities and Income Fund | |||
KNOV | 27.28 | 0.06 | +0.24% |
Innovator U.S. Small Cp Pwr Buf ETF -Nov | |||
BEMB | 54.28 | 0.05 | +0.09% |
iShares J.P. Morgan Brd USD Emr MktBdETF | |||
MPRO | 30.61 | -0.11 | -0.36% |
Monarch ProCap ETF |